Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Volume 27, Issue 18
  5. Article
Volume 27, Issue 18
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

A drug delivery system is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Such systems release the drugs at specific amounts in a specific site. The carbon based-nanomaterials have been actively used as drug carriers to treat various cancer.

Objective

This study aimed to evaluate the cytotoxic effects of DOX-GO, DOX-OMC and DOX-CNT in colon cancer cells (HT29).

Methods

We reported platforms based on graphene oxide (GO), ordered mesoporous carbon (OMC) and carbon nanotubes (CNT) to conjugate with doxorubicin (DOX). The conjugation of DOX with carbon nanomaterial was investigated by UV-Vis spectroscopy, field emission scanning electron microscope (FE-SEM) and cyclic voltammetry (CV) methods.

Results

We showed that graphene oxide was a highly efficient matrix. Efficient loading of DOX, 89%, 78%, and 73.5% at pH 7.0 was seen onto GO, OMC and CNT, respectively. Upon pH 4. 0 after 15 h, 69%, 61% and 61% of DOX could be released from the DOX-GO, DOX-OMC and DOX-CNT, respectively, which illustrated the significant benefits of the developed approach for carbon nanomaterial applications. cytotoxicity analysis showed greater cytotoxicity of DOX/GO, DOX/OMC and DOX/CNT in comparison with GO, OMC and CNT against HT29 colon cancer cells with cell viability of 22%, 40% and 44% after 48 h for DOX-GO, DOX-OMC and DOX-CNT, respectively.

Conclusion

The nanohybrids based on DOX-carbon nanomaterial, because of their unique physical and chemical properties, will remarkably enhance the anti-cancer activity.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207326666230821145508
2023-10-12
2025-01-13

  • From This Site

    /content/journals/cchts/10.2174/1386207326666230821145508
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhaoZ. UkidveA. KimJ. MitragotriS. Targeting strategies for tissue-specific drug delivery.Cell.2020181115116710.1016/j.cell.2020.02.001 32243788
     [Google Scholar]
  2. AmiriM. KhazaeliP. SalehabadiA. Salavati-NiasariM. Hydrogel beads-based nanocomposites in novel drug delivery platforms: Recent trends and developments.Adv. Colloid. Interface. Sci.202128810231610.1016/j.cis.2020.102316 33387892
     [Google Scholar]
  3. LiC. WangJ. WangY. GaoH. WeiG. HuangY. YuH. GanY. WangY. MeiL. ChenH. HuH. ZhangZ. JinY. Recent progress in drug delivery.Acta Pharm. Sin. B.2019961145116210.1016/j.apsb.2019.08.003 31867161
     [Google Scholar]
  4. RezaeifarM. MahmoudvandH. AmiriM. Formulation and evaluation of diphenhydramine gel using different gelling agents.Der. Pharma. Chem.20168243249
     [Google Scholar]
  5. MitchellM.J. BillingsleyM.M. HaleyR.M. WechslerM.E. PeppasN.A. LangerR. Engineering precision nanoparticles for drug delivery.Nat. Rev. Drug Discov.202120210112410.1038/s41573‑020‑0090‑8 33277608
     [Google Scholar]
  6. PatraJ.K. DasG. FracetoL.F. CamposE.V.R. Rodriguez-TorresM.P. Acosta-TorresL.S. Diaz-TorresL.A. GrilloR. SwamyM.K. SharmaS. HabtemariamS. ShinH.S. Nano based drug delivery systems: Recent developments and future prospects.J. Nanobiotechnol.20181617110.1186/s12951‑018‑0392‑8 30231877
     [Google Scholar]
  7. ManzanoM. Vallet-RegíM. Mesoporous silica nanoparticles for drug delivery.Adv. Funct. Mater.2020302190263410.1002/adfm.201902634
     [Google Scholar]
  8. HanH.J. EkweremaduC. PatelN. Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer.J. Drug Deliv. Sci. Technol.2019521051106010.1016/j.jddst.2019.05.024
     [Google Scholar]
  9. BeginesB. OrtizT. Pérez-ArandaM. MartínezG. MerineroM. Argüelles-AriasF. AlcudiaA. Polymeric nanoparticles for drug delivery: Recent developments and future prospects.Nanomaterials.2020107140310.3390/nano10071403 32707641
     [Google Scholar]
  10. ZhangG. ZengX. LiP. Nanomaterials in cancer-therapy drug delivery system.J. Biomed. Nanotechnol.20139574175010.1166/jbn.2013.1583 23802404
     [Google Scholar]
  11. DebnathS.K. SrivastavaR. Drug delivery with carbon-based nanomaterials as versatile nanocarriers: Progress and prospects.Front. Nanotechnol.2021364456410.3389/fnano.2021.644564
     [Google Scholar]
  12. MaitiD. TongX. MouX. YangK. Carbon-based nanomaterials for biomedical applications: A recent study.Front. Pharmacol.20199140110.3389/fphar.2018.01401 30914959
     [Google Scholar]
  13. SajjadiM. NasrollahzadehM. JalehB. SoufiG.J. IravaniS. Carbon-based nanomaterials for targeted cancer nanotherapy: Recent trends and future prospects.J. Drug. Target.202129771674110.1080/1061186X.2021.1886301 33566719
     [Google Scholar]
  14. JampilekJ. KralovaK. Advances in drug delivery nanosystems using graphene-based materials and carbon nanotubes.Materials.2021145105910.3390/ma14051059 33668271
     [Google Scholar]
  15. MohajeriM. BehnamB. SahebkarA. Biomedical applications of carbon nanomaterials: Drug and gene delivery potentials.J. Cell. Physiol.2019234129831910.1002/jcp.26899 30078182
     [Google Scholar]
  16. MahajanS. PatharkarA. KucheK. MaheshwariR. DebP.K. KaliaK. TekadeR.K. Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer.Int. J. Pharm.2018548154055810.1016/j.ijpharm.2018.07.027 29997043
     [Google Scholar]
  17. ChakrabortyS. RahmanT. The difficulties in cancer treatment.Ecancermedicalscience.20126ed16 24883085
     [Google Scholar]
  18. LindleyC. McCuneJ.S. ThomasonT.E. LauderD. SaulsA. AdkinsS. SawyerW.T. Perception of chemotherapy side effects cancer versus noncancer patients.Cancer. Pract.199972596510.1046/j.1523‑5394.1999.07205.x 10352062
     [Google Scholar]
  19. ZhaoN. C WoodleM. MixsonA.J. Advances in delivery systems for doxorubicin.J. Nanomed. Nanotechnol.20189551952610.4172/2157‑7439.1000519 30613436
     [Google Scholar]
  20. ChristidiE. BrunhamL.R. Regulated cell death pathways in doxorubicin-induced cardiotoxicity.Cell. Death. Dis.202112433910.1038/s41419‑021‑03614‑x 33795647
     [Google Scholar]
  21. RawatP.S. JaiswalA. KhuranaA. BhattiJ.S. NavikU. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.Biomed. Pharmacother.202113911170810.1016/j.biopha.2021.111708 34243633
     [Google Scholar]
  22. ZareyyB. ChekinF. FathiS. NiO/porous reduced graphene oxide as active hybrid electrocatalyst for oxygen evolution reaction.Russ. J. Electrochem.201955433333810.1134/S102319351903011X
     [Google Scholar]
  23. LadmakhiH.B. ChekinF. FathiS. RaoofJ.B. Electrochemical sensor based on magnetite graphene oxide/ordered mesoporous carbon hybrid to detection of allopurinol in clinical samples.Talanta202021112075910.1016/j.talanta.2020.120759 32070564
     [Google Scholar]
  24. HazhirN. ChekinF. RaoofJ.B. FathiS. A porous reduced graphene oxide/chitosan-based nanocarrier as a delivery system of doxorubicin.RSC Adv.2019953307293073510.1039/C9RA04977K 35529364
     [Google Scholar]
  25. TehraniN.S. MasoumiM. ChekinF. BaeiM.S. Nitrogen doped porous reduced graphene oxide hybrid as a nanocarrier of imatinib anti-cancer drug.Russ. J. Appl. Chem.20209381221122810.1134/S1070427220080157
     [Google Scholar]
  26. HazhirN. ChekinF. RaoofJ.B. FathiSh. Anticancer activity of doxorubicin conjugated to polymer/carbon based-nanohybrid against MCF-7 breast and HT-29 colon cancer cells.Int. J. Nanodimens.2021121119
     [Google Scholar]
  27. KavinkumarT. VarunkumarK. RavikumarV. ManivannanS. Anticancer activity of graphene oxide-reduced graphene oxide-silver nanoparticle composites.J. Colloid Interface Sci.20175051125113310.1016/j.jcis.2017.07.002 28704918
     [Google Scholar]
/content/journals/cchts/10.2174/1386207326666230821145508
Loading
Conjugation of Doxorubicin and Carbon-based-nanostructures for Drug Delivery against HT-29 Colon Cancer Cells
Comb Chem High Throughput Screen 27, 2726 (2024); https://doi.org/10.2174/1386207326666230821145508
/content/journals/cchts/10.2174/1386207326666230821145508
/content/journals/cchts/10.2174/1386207326666230821145508
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): carbon nanotubes; colon cancer cells; cyclic voltammetry (CV); Doxorubicin; graphene oxide; ordered mesoporous carbon

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test